Department of Health, Human Performance, and Recreation, Baylor University, Waco, Texas, United States.
Department of Human Sciences and Design, Baylor University, Waco, Texas, United States.
Am J Physiol Regul Integr Comp Physiol. 2024 Mar 1;326(3):R254-R265. doi: 10.1152/ajpregu.00208.2023. Epub 2024 Jan 22.
Cachexia is a muscle-wasting syndrome commonly observed in patients with cancer, which can significantly worsen clinical outcomes. Because of a global rise in obesity, the coexistence of cachexia in obese individuals poses unique challenges, with the impact of excessive adiposity on cachexia severity and underlying pathophysiology not well defined. Understanding the interplay between cachexia and obesity is crucial for improving diagnosis and treatment strategies for these patients; therefore, the present study examined differences in cachexia between lean and obese mice bearing Lewis lung carcinoma (LLC) tumors. Nine-week-old, male C57Bl6J mice were placed on either a chow or a high-fat diet (HFD) for 9 wk. After the diet intervention, mice were inoculated with LLC or vehicle. Markers of cachexia, such as body and muscle loss, were noted in both chow and HFD groups with tumors. Tumor weight of HFD animals was greater than that of chow. LLC tumors reduced gastrocnemius, plantaris, and soleus mass, regardless of diet. The tibialis anterior and plantaris mass and cross-sectional area of type IIb/x fibers in the gastrocnemius were not different between HFD-chow, HFD-tumor, and chow-tumor. Using RNA sequencing (RNA-seq) of the plantaris muscle from chow-tumor and HFD-tumor groups, we identified ∼400 differentially expressed genes. Bioinformatic analysis identified changes in lipid metabolism, mitochondria, bioenergetics, and proteasome degradation. Atrophy was not greater despite larger tumor burden in animals fed an HFD, and RNA-seq data suggests that partial protection is mediated through differences in mitochondrial function and protein degradation, which may serve as future mechanistic targets. This study provides timely information on the interaction between obesity and cancer cachexia. Lean and obese animals show signs of cachexia with reduced body weight, adipose tissue, and gastrocnemius muscle mass. There was not significant wasting in the tibialis anterior, plantaris, or fast twitch fibers in the gastrocnemius muscle of obese animals with tumors. RNA-seq analysis reveals that obese tumor bearing animals had differential expression of mitochondria- and degradation-related genes, which may direct future studies in mechanistic research.
恶病质是一种常见于癌症患者的肌肉消耗综合征,可显著恶化临床结局。由于肥胖在全球范围内的上升,恶病质在肥胖个体中的共存带来了独特的挑战,过度肥胖对恶病质严重程度和潜在病理生理学的影响尚不清楚。了解恶病质和肥胖之间的相互作用对于改善这些患者的诊断和治疗策略至关重要;因此,本研究检查了携带 Lewis 肺癌 (LLC) 肿瘤的瘦鼠和肥胖鼠之间恶病质的差异。将 9 周龄雄性 C57Bl6J 小鼠置于标准饮食 (chow) 或高脂肪饮食 (HFD) 中 9 周。饮食干预后,小鼠接种 LLC 或载体。在 Chow 和 HFD 组中,无论饮食如何,均观察到恶病质标志物(如体重和肌肉损失)。HFD 动物的肿瘤重量大于 Chow。LLC 肿瘤减少了比目鱼肌、跖肌和跖肌的质量,而不管饮食如何。HFD-chow、HFD-tumor 和 Chow-tumor 之间的胫骨前肌和跖肌质量以及比目鱼肌 IIb/x 纤维的横截面积没有差异。使用 Chow-tumor 和 HFD-tumor 组跖肌的 RNA 测序 (RNA-seq),我们鉴定了约 400 个差异表达基因。生物信息学分析鉴定了脂质代谢、线粒体、生物能量和蛋白酶体降解的变化。尽管 HFD 喂养的动物肿瘤负担更大,但萎缩程度没有增加,RNA-seq 数据表明,部分保护是通过线粒体功能和蛋白质降解的差异介导的,这可能成为未来的机制靶点。本研究提供了关于肥胖与癌症恶病质相互作用的及时信息。瘦鼠和肥胖鼠都表现出恶病质的迹象,体重、脂肪组织和比目鱼肌质量减少。在肿瘤肥胖动物的胫骨前肌、跖肌或比目鱼肌的快肌纤维中,没有明显的消瘦。RNA-seq 分析显示,肥胖肿瘤荷瘤动物的线粒体和降解相关基因表达差异,这可能指导未来的机制研究。